XML 39 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Commitments and Contingencies - CyDex License Agreement - Additional Information (Detail) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2017
Dec. 31, 2016
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2015
Commitments And Contingencies [Line Items]            
Research and development expense $ 58,286,000   $ 29,075,000 $ 159,386,000 $ 78,752,000  
CyDex License Agreement [Member]            
Commitments And Contingencies [Line Items]            
Research and development expense           $ 100,000
Research and development expense related to milestone expense 0     0    
Milestone payments 0     0    
CyDex License Agreement [Member] | First and Second Clinical Development Milestones [Member] | Brexanolone [Member] | Maximum [Member]            
Commitments And Contingencies [Line Items]            
Expected milestone payments 800,000     800,000    
CyDex License Agreement [Member] | First and Second Regulatory Milestones [Member] | Brexanolone [Member] | Maximum [Member]            
Commitments And Contingencies [Line Items]            
Expected milestone payments 3,800,000     3,800,000    
CyDex License Agreement [Member] | Third and Fourth Clinical Development Milestones [Member] | Brexanolone [Member] | Maximum [Member]            
Commitments And Contingencies [Line Items]            
Expected milestone payments 1,300,000     1,300,000    
CyDex License Agreement [Member] | Third and Fourth Regulatory Milestones [Member] | Brexanolone [Member] | Maximum [Member]            
Commitments And Contingencies [Line Items]            
Expected milestone payments 8,500,000     8,500,000    
CyDex License Agreement [Member] | Clinical Development [Member]            
Commitments And Contingencies [Line Items]            
Research and development expense related to milestone expense   $ 500,000 $ 300,000      
CyDex License Agreement [Member] | Clinical Development [Member] | SAGE-689 [Member] | Maximum [Member]            
Commitments And Contingencies [Line Items]            
Expected milestone payments 800,000     800,000    
CyDex License Agreement [Member] | Regulatory Milestones [Member] | SAGE-689 [Member] | Maximum [Member]            
Commitments And Contingencies [Line Items]            
Expected milestone payments $ 1,800,000     $ 1,800,000